EXG:NYSE, Eaton Vance Tax-Managed Global Diversified Equity Income Fund

EXG stock overview

Eaton Vance Tax-Managed Global Diversified Equity Income Fund (EXG:NYSE) closed at $9.32 on October 23, 2026, down 0.75% on the day. The stock trades 8.3% below its 52-week high of $10.16 and 13.0% above its 52-week low of $8.25. Eaton Vance Tax-Managed Global Diversified Equity Income Fund is part of the Miscellaneous sector.

Key figures

Price
$9.32
Day change
-0.75%
Volume
367,727
Average volume
447,020
Market cap
2B+
52-week range
$8.25 – $10.16
50-day average
$9.67
200-day average
$9.51

Price action over the past year

In 252 trading sessions since October 23, 2025, EXG closed higher on 125 days (50%). Its best day was March 31, 2026 (+4.59%) and its worst was May 15, 2026 (-2.75%). It never moved 10% or more in a single session.

About Eaton Vance Tax-Managed Global Diversified Equity Income Fund

Eaton Vance Global Diversified Equity Income Fund (the Fund) is a diversified, closed-end investment company. The Fund was established to offer investors sources of potential tax-advantaged income and gains. The Fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The Fund pursues its investment objectives by investing primarily in a diversified portfolio of domestic and foreign common stocks. The Fund invests primarily in dividend-paying domestic and foreign common stocks that qualify for favorable federal income tax treatment. In addition, the Fund writes (sells) stock index call options with respect to a portion of its common stock portfolio value. The Fund's 10 largest equity holdings as of October 31, 2007, included Enel SPA, Nokia Oyj ADR, ENI SPA, Royal Dutch Shell PLC, BP PLC, Cesky Telecom AS, GlaxoSmithKline PLC, EMC Corp., HSBC Holdings PLC and Anadarko Petroleum Corp.

Similar stocks

Find more stocks like EXG with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.